BioLabs (Nasdaq: AIDX), an early market entrant in cutting-edge, AI powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, today provided an ...

Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...

ClearNote Health's enhanced Avantect Pancreatic Cancer Test features industry-leading detection sensitivity and specificity ...

A blood sample does not have an obvious odor to a person in a lab coat. But to an electronic nose, it can carry a chemical signature that points toward disease. In a new study from Linköping ...

Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

New research shows an AI-driven liquid biopsy analyzing genome-wide cfDNA fragment patterns can detect early liver fibrosis & cirrhosis and may signal broader chronic disease burden.

What if people could detect cancer and other diseases with the same speed and ease of a pregnancy test or blood glucose meter? Researchers at the Carl R. Woese Institute for Genomic Biology are a step ...

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced the launch of its enhanced Avantect(R) Pancreatic Cancer Test, which delivers ...